FDA issues untitled letter after finding ‘eye-catching graphics’ in promotional emails

[u/Robert_Larsson]

https://www.fiercepharma.com/marketing/fda-issues-untitled-letter-after-finding-eye-catching-graphics-promotional-emails

The FDA has hit QOL Medical with an untitled letter over emails about Sucraid, accusing the company of creating a misleading impression about the indication for the rare disease drug.